Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Zimmer and Anika expand Orthovisc deal:

This article was originally published in Clinica

Executive Summary

Zimmer and Anika Therapeutics have extended their exclusive, multi-year distribution agreement for Orthovisc, an injectable product based on hyaluronic acid to restore the elasticity and viscosity of the synovial fluid. Under the new agreement, Zimmer will sell the product in Europe and Latin America. Anika will receive up to $3.5 million. The two companies' initial agreement covered the US, Canada and certain Asia-Pacific countries.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT081656

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel